Skip to main content

Think-tank claims Sox has 'reduced risk taking in US'

PITTSBURGH - The Sarbanes-Oxley Act (Sox) has led to a significant drop in risk-taking behaviour by US firms compared to their UK counterparts since the inception of the accounting law, says major new research. In a report, Sarbanes-Oxley and Corporate Risk-Taking , researchers from the Katz School of Business at the University of Pittsburgh investigated three distinct measures of risk-taking to conclude: "Sox has chilled risk-taking by US corporations."

The report, which used 16-year old data and sampled 5,228 UK and US firms, looked at accounting-based risk measures in relation to research and development (R&D) and capital expenditure. It measured stock-based risk and found a decrease in market risk, equity risk and firm-specific risk since Sox, compared with UK counterparts. The largest decline was seen in high risk, R&D-intensive industries

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Emerging trends in op risk

Karen Man, partner and member of the global financial institutions leadership team at Baker McKenzie, discusses emerging op risks in the wake of the Covid‑19 pandemic, a rise in cyber attacks, concerns around conduct and culture, and the complexities of…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here